Search for Clinical Trial Results

Sponsored By

Carcinosarcoma - 15 Studies Found

Status Study
Active, not recruiting Study Name: Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer
Condition:
  • Endometrial Adenocarcinoma
  • Endometrial Endometrioid Adenocarcinoma
  • Breast Carcinoma
  • Endometrial Clear Cell Adenocarcinoma
  • End
    Date: 2016-08-17
    Interventions:
    • Drug: Metformin Hydrochloride

Completed Study Name: APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion
Condition: Fallopian Tube Carcinosarcoma
Date: 2025-11-04
Interventions: Given IV
Completed Study Name: A Study of FRaDCs for Ovarian Cancer
Condition: Fallopian Tube Carcinosarcoma
Date: 2025-11-04
Interventions: Undergo biopsy
Completed Study Name: A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma
Condition: Endometrial Carcinosarcoma
Date: 2025-11-04
Interventions: Pembrolizumab will be administered intravenously (IV) at 200mg every 3 weeks.
<<< Previous